The role of fecal occult blood testing in screening for colorectal cancer

Practical Gastroenterology

Volumn 31, Issue 6, 2007, Pages 20-32

  Allison, James E ^a,b  

^a Division of Gastroenterology SFGH

^b Kaiser Division of Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; HUMAN; MASS SCREENING; OCCULT BLOOD; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; REVIEW; UNITED STATES;

EID: 34347407664     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Smith RA, von Eschenbach A, Wender R, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin, 2001;51:38-75.
2. Screening for Colorectal Cancer: recommendation and Rationale US Preventive Services Task Force. Ann Intern Med, 2002;137:129-131.
3. Winawer SJ, Fletcher RH, Rex D, Bond J, Burt R, et al. Colorectal Cancer Screening and Surveillance: Clinical Guidelines and Rationale U.S Multisociety Task Force on Colorectal Cancer. Gastroenterology, 2003;124:544-560.
4. Podolsky DK. Going the Distance B: The Case for True Colorectal B Cancer Screening. Editorial, NEJM, 2000;343:207-208.
5. Detsky AS. Screening for Colon Cancer- Can we afford colonoscopy? Editorial, NEJM, 2001; 345:607-608.
6. Cram P, Fendrick MA, Inadomi J, et al. The impact of a celebrity promotional campaign on the use of colon cancer screening. Arch Intern Med, 2003; 1601-1605.
7. Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol, 2000;95:868-877.
8. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, et al. Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer. NEJM, 2000; 343:162-168.
9. Lieberman DA, Weiss DG, et al. One B Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon. NEJM, 2001;345:555-560.
10. Imperiale T. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. NEJM, 2000;352:2061-2068.
11. Simon JB. Occult blood screening for colorectal carcinoma: A critical review. Gastroenterology, 1985;88:820-837.
12. Irons GV, Kirsner JB. Routine chemical test of the stool for occult blood: an evaluation. Am J Med Sci, 1965; 249:247-260.
13. Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA, 1967; 201:943-945.
14. Sinatra M, St John DJB, Young GP. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable. Clin Chem, 1999; 45:123-126.
15. Rozen P, Knaani J, Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci, 1997;42:2064-2071.
16. Walsh JME, Terdiman JP. Colorectal Cancer Screening Clinical Applications. JAMA, 2003;289:1297-1302.
17. Collins JF, Lieberman DA, Durbin TE, Weiss DG, et al. Accuracy of screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice. Ann Intern Med, 2005;142:81-85.
18. Allison JE, Feldman R, Tekawa I. Hemoccult screening in detecting colorectal neoplasms: sensitivity, specificity, and predictive value. Ann Intern Med, 1999; 112:328-333.
19. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult blood tests for colorectal cancer screening. NEJM, 1996;334:155-159.
20. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal- occult-blood screening for colorectal cancer. Lancet, 1996; 348:1472-1477.
21. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 1996; 348:1467-1471.
22. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. NEJM, 1993; 328:1365-1371. {Erratum. NEJM, 1993; 329; 672.}
23. Niv Y. Fecal Occult blood test: the importance of proper evaluation. J Clin Gastroenterol, 1990;12:393-395.
24. Fleisher M, Winawer SJ, Zauber AG, Smith C, Schwartz MK. Accuracy of fecal occult blood test interpretation: National Polyp Study Work Group. Ann Intern Med, 1991;114: 875-876.
25. Selinger RRE, Norman S, Dominitz JA. Failure of Health Care Professionals to Interpret Fecal Occult Blood Tests Accurately. Am J Med, 2003;114:64-67.
26. Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med, 1975;83:824-826.
27. Cole SR, Young GP. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust, 2001;175:195-198.
28. Young GP, St. John JB, Winawer SJ, et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. Am J Gastroenterol, 2002; 97:2499-2507.
29. Allison JE, Levin TR, Sakoda L, et al. The new fecal occult blood tests have poor application sensitivity for significant polyps in average risk subjects. Gastroenterology, 2002;122(Suppl 1):A592.
30. Cole SR, Young GP, Esterman A, et al. randomized trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen, 2003;10:117-122.
31. Vilkin A, Rozen P, Waked A, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol, 2005;100:2519-2525.
32. Morikawa T, Kato J, Yamaji Y, et al. Comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology, 2005;129:422-428.
33. Nakama H, Kamijo N, Fujimori K, et al. Relationship between fecal sampling times and sensitivity and specificity of immunochemical fecal occult blood tests for colorectal cancer: a comparative study. Dis Colon Rectum, 1997;40:781-784.
34. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. NEJM, 2000; 343:162-168.
35. Lieberman DA, Weiss DG, the Veterans Affairs Cooperative Study Group. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. NEJM, 2001;345:555-560.
36. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. NEJM, 2000;352:2061-2068.
37. Schoenfeld P, Cash B, Flood A, Dobhan R. Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia. NEJM, 2005;352:2061-2068.
38. Ransohoff DF. Lessons from the UK sigmoidoscopy screening trial. Editorial, Lancet, 2002; 359:1266-1267.
39. Stryker S, Wolff B, Culp C, et al. Natural history of untreated colonic polyps. Gastroenterology, 1987;93:1009-1013.
40. Eide T. Risk of colorectal cancer in adenoma bearing individuals within a defined population. Int J Cancer, 1986;38:173-176.
41. Davila RE, Rajan E, Baron TH, Adler DG, Egan JV, Faigel DO, Gan SI, Hirota WK, Leighton JA, Lichtenstein D, et al. ASGE guideline: Colorectal cancer screening and surveillance. Gastrointest Endosc, 2006; 63:546-557.
42. Seef LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population of the United States? Gastroenterology, 2004; 127:1661-1669.
43. Levin TR. Colonoscopy capacity: Can we build it? Will they come? Editorial, Gastroenterology, 2004;127:1841-1849.
44. Ladabaum R, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology, 2005;129:1151-1162.
45. Wendt E. Letter to the editor. NEJM, 2001; 345:1851.
46. Woolf SH. The best screening test for colorectal cancer: a personal choice. Editorial, NEJM, 2000; 343:1641-1643.
47. Allison JE. Screening for colorectal cancer 2003: Is there still a role for the FOBT? Techn Gastrointest Endosc, 2003; 5:127-133.
48. Macafee DAL, Scholefield JH. Population based endoscopic screening for colorectal cancer. Gut, 2003;52:323-326.
49. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy, does reimurbursement cover costs? Ann Intern Med, 1999;130:525-530.
50. Shaheen NJ, Ransohoff DF. Sigmoidoscopy costs and the limits of altruism. Am J Med, 1999; 107:286-287.
51. Fletcher RH. Screening sigmoidoscopy - How often and how good? Editorial, JAMA, 2003; 290:106-108.
52. Colorectal cancer. http://www.preventcancer.org/colorectal. Accessed 8/25/06.